These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35290801)

  • 1. Spatial CRISPR genomics identifies regulators of the tumor microenvironment.
    Dhainaut M; Rose SA; Akturk G; Wroblewska A; Nielsen SR; Park ES; Buckup M; Roudko V; Pia L; Sweeney R; Le Berichel J; Wilk CM; Bektesevic A; Lee BH; Bhardwaj N; Rahman AH; Baccarini A; Gnjatic S; Pe'er D; Merad M; Brown BD
    Cell; 2022 Mar; 185(7):1223-1239.e20. PubMed ID: 35290801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors.
    Tang N; Cheng C; Zhang X; Qiao M; Li N; Mu W; Wei XF; Han W; Wang H
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31999649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.
    Codina A; Renauer PA; Wang G; Chow RD; Park JJ; Ye H; Zhang K; Dong MB; Gassaway B; Ye L; Errami Y; Shen L; Chang A; Jain D; Herbst RS; Bosenberg M; Rinehart J; Fan R; Chen S
    Cell Syst; 2019 Feb; 8(2):136-151.e7. PubMed ID: 30797773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
    Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells.
    Herzfeldt AK; Gamez MP; Martin E; Boryn LM; Baskaran P; Huber HJ; Schuler M; Park JE; Swee LK
    Elife; 2023 Sep; 12():. PubMed ID: 37732732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer CRISPR Screens In Vivo.
    Chow RD; Chen S
    Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma.
    Ji AL; Rubin AJ; Thrane K; Jiang S; Reynolds DL; Meyers RM; Guo MG; George BM; Mollbrink A; Bergenstråhle J; Larsson L; Bai Y; Zhu B; Bhaduri A; Meyers JM; Rovira-Clavé X; Hollmig ST; Aasi SZ; Nolan GP; Lundeberg J; Khavari PA
    Cell; 2020 Jul; 182(2):497-514.e22. PubMed ID: 32579974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CRISPR Platform for Targeted In Vivo Screens.
    Maranda V; Zhang Y; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
    Methods Mol Biol; 2023; 2614():397-409. PubMed ID: 36587138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling.
    Fix SM; Forget MA; Sakellariou-Thompson D; Wang Y; Griffiths TM; Lee M; Haymaker CL; Dominguez AL; Basar R; Reyes C; Kumar S; Meyer LA; Hwu P; Bernatchez C; Jazaeri AA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35882447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblast spatial heterogeneity and
    Honda CK; Kurozumi S; Fujii T; Pourquier D; Khellaf L; Boissiere F; Horiguchi J; Oyama T; Shirabe K; Colinge J; Yokobori T; Turtoi A
    Theranostics; 2024; 14(5):1873-1885. PubMed ID: 38505604
    [No Abstract]   [Full Text] [Related]  

  • 11. TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.
    Perez-Penco M; Lara de la Torre L; Lecoq I; Martinenaite E; Andersen MH
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38417917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in CRISPR screens for the development of cancer immunotherapy strategies.
    Li YR; Lyu Z; Tian Y; Fang Y; Zhu Y; Chen Y; Yang L
    Mol Ther Oncolytics; 2023 Dec; 31():100733. PubMed ID: 37876793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
    Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
    Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPRi functional genomics in bacteria and its application to medical and industrial research.
    Enright AL; Heelan WJ; Ward RD; Peters JM
    Microbiol Mol Biol Rev; 2024 Jun; 88(2):e0017022. PubMed ID: 38809084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Pooled CRISPR-Screening the Dawn of a New Era for Functional Genomics.
    Yao J; Dai HL
    Adv Exp Med Biol; 2018; 1068():171-176. PubMed ID: 29943304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens.
    Schlabach MR; Lin S; Collester ZR; Wrocklage C; Shenker S; Calnan C; Xu T; Gannon HS; Williams LJ; Thompson F; Dunbar PR; LaMothe RA; Garrett TE; Colletti N; Hohmann AF; Tubo NJ; Bullock CP; Le Mercier I; Sofjan K; Merkin JJ; Keegan S; Kryukov GV; Dugopolski C; Stegmeier F; Wong K; Sharp FA; Cadzow L; Benson MJ
    J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immunology CRISPR screening: present, past, and future.
    Dong MB; Tang K; Zhou X; Zhou JJ; Chen S
    Trends Cancer; 2022 Mar; 8(3):210-225. PubMed ID: 34920978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9.
    Rojas-Fernandez A; Herhaus L; Macartney T; Lachaud C; Hay RT; Sapkota GP
    Sci Rep; 2015 Apr; 5():9811. PubMed ID: 25922883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8
    Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.